Today, Ontario announced it will invest up to $50 million in venture capital funds focused on life sciences.
The Ontario Capital Growth Corporation (OCGC) has issued an expression of interest to identify fund managers to partner with other institutional investors such as corporations, banks and pension funds.
Budget 2018 proposes an investment of nearly $4 billion in Canada’s research system. Robert Merson, Management Consultant, has prepared an analysis of this year's Budget 2018, focusing on research and innovation investment.
This week, in Part 2 of a blog that began last week, we review the Niagara Emerging Health Science Company Forum, held in Niagara-on-the-Lake on Feb 1-2, 2018.
The forum brought together CEOs and senior executives from high potential Canadian health science companies with senior leadership from American investors and strategics in beautiful Niagara-on-the-Lake for two days of panel presentations, executive roundtables, and networking dinners.
OBIO is working to develop a model that will advance early access to the Ontario market. Critical to the development of this initiative is the ability to quantify the Ontario health science technology pipeline by category and stage of readiness to address the barriers to market access.
Hamilton Health Sciences & IBM's innovation exchange provides innovators – research scientists, industry & academic partners, start-ups and scale-ups – with technologies they otherwise would not have access to, to advance the pursuit of solutions to challenges in healthcare.
Nanovista Inc., a start-up company co-founded by Drs. David Jaffray, Jinzi Zheng, and Christine Allen of UHN and the University of Toronto, recently received investments of $1.8M with the help of GreenSky Capital Inc. and its affiliated venture capital funds.
Nanovista also recently welcomed Steven Chackowicz as its new CEO. A serial entrepreneur, he has experience in leadership roles in companies that include Exact Imaging, Aspect Imaging and VisualSonics.
Springboard’s Health Innovation Hub is a program for women-led life science and digital health companies seeking seed and growth funding and expert connections. The program runs in two tracks: Life Science and Digital Health.
Selected companies will be matched with a team of relevant, targeted advisors and participate in several in-person and virtual workshops and presentation sessions throughout the year that provide exposure to influencers, active investors, and potential strategic partners.